Влияние степени нарушений углеводного обмена на тяжесть артериальной гипертонии, распространенность и выраженность поражения органов-мишеней у больных с метаболическим синдромом
- Авторы: Жернакова ЮВ1, Чазова ИЕ1, Шарипова ГХ1, Олимпиева СП1, Киликовский ВВ1
-
Учреждения:
- Институт клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, Москва
- Выпуск: Том 8, № 4 (2011)
- Страницы: 68-74
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2075-082X/article/view/33172
- DOI: https://doi.org/10.26442/SG33172
- ID: 33172
Цитировать
Полный текст
Аннотация
Об авторах
Ю В Жернакова
Институт клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, МоскваИнститут клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, Москва
И Е Чазова
Институт клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, МоскваИнститут клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, Москва
Г Х Шарипова
Институт клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, МоскваИнститут клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, Москва
С П Олимпиева
Институт клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, МоскваИнститут клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, Москва
В В Киликовский
Институт клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, МоскваИнститут клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, Москва
Список литературы
- World Health Organization 2008-2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. Geneva: WHO, 2008.
- Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
- Carr DB, Utzschneider KM, Hull RL et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-94.
- Julius S, Gudbrandsson T, Jamerson K et al The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983-86.
- Mule G, Nardi E, Cottone S et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257: 503-13.
- Schilacci G, Pirro M, Vaudo G et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 2005; 45: 1978-82.
- Cuspidi C, Meani S, Fusi V et al Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study. J Hypertens 2005; 23: 875-82.
- Kavamoto R, Tomita H, Oka Y et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med 2005; 44: 1232-38.
- Cuspidi C, Meani S, Fusi V et al. Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals. J Hypertens 2005; 23: 1589-95.
- Mulè G, Nardi E, Cottone S et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257 (6): 503-13.
- Navarro J, Redón J, Cea-Calvo L et al. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERICHTA study. Blood Press 2007; 16 (1): 20-7.
- Cuspidi C, Meani S, Valerio C et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 2007; 20 (3): 296-303.
- Cuspidi C, Sala C, Zanchetti A. Metabolic syndrome and target organ damage: role of blood pressure. Expert Rev Cardiovasc Ther 2008; 6 (5): 731-43.
- Cuspidi C, Valerio C, Giudici V et al. Metabolic syndrome and multiple organ damage in essential hypertension. Blood Pressure 2008; 17: 195-203.
- Eguchi K, Schwartz JE, Roman MJ et al. Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population. J Clin Hypertens (Greenwich) 2007; 9 (5): 337-44.
- Recommendations for Chamber Quantification: A Report from the American Society of Еchocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with European Association of Echocardiography. J Am Soc Echocardiogr 2005; 18: 1446-7.
- Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871-78.
- Agabiti-Rosei E, Muiesan ML, Salvetti M. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy. J Am Soc Nephrol 2006; 17 (4 Suppl. 2): S104-8.
- Ferrara LA, Cardoni O, Mancini M, Zanchetti A. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens 2007; 21 (10): 795-601.
- Chang Y, Yoo T, Ryu S et al. Abdominal obesity, systolic bood pressure and MAU in normotensive and euglicemic Korean men. Int. Obes (lond) 2006; 30 (5): 800-4.
- Takiuchi S, Kamide K, Miwa Y et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 2004; 18 (1): 17-23.
- Cirillo M, Senigalliesi L, Laurenzi M et al. Microalbuminuria in nondiabetic adults; relations of blood pressure, body mass index, plasma cholesterol levels and smoking The GUBBIO Population Study. Arch Intern Med 1998; 158 (17): 1933-39.
- Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-74.
- De Simone G, Olsen MH, Wachtell K et al. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study. J Hum Hypertens 2007; 21 (8): 625-32.